Pfizer-Biohaven Pharmaceuticals US antitrust waiting period expired June 27; deal already cleared in Austria, Germany
MLex Summary: The mandatory US antitrust waiting period for Pfizer's acquisition of Biohaven Pharmaceuticals expired June 27, according to a Biohaven securities filing. The deal has already been cleared by antitrust...To view the full article, register now.
Already a subscriber? Click here to view full article